Navigation Links
Uroplasty Reports Fiscal Third Quarter 2013 Financial Results
Date:1/24/2013

833)(2,717,038)Cash flows from investing activities:  Proceeds from maturity of held-to-maturity investments

5,000,0003,500,000  Proceeds from maturity of available-for-sale investments

3,200,0009,518,252  Purchases of held-to-maturity investments

(2,500,000)(7,640,000)  Purchases of available-for-sale investments

(4,921,036)(3,046,270)  Purchases of property, plant and equipment

(137,101)(222,826)  Proceeds from sale of property, plant and equipment

7,038-  Purchase of intangible assets

(4,440)(77,738)Net cash provided by investing activities

644,4612,031,418Cash flows from financing activities:  Net proceeds from exercise of options

150,000208,825Net cash provided by financing activities

150,000208,825Effect of exchange rate changes on cash and cash equivalents

(6,313)(26,208)Net increase (decrease) in cash and cash equivalents

156,315(503,003)Cash and cash equivalents at beginning of period

4,653,2266,063,573Cash and cash equivalents at end of period

$4,809,541$5,560,570Cash paid during the period for interest

$12$57Cash paid during the period for income taxes

42,31931,307 

Non-GAAP Financial Measures:  The following table reconciles our operating loss calculated in accordance with accounting principles generally accepted in the U.S. (GAAP) to non-GAAP financial measures that exclude non-cash charges for share-based compensation, and depreciation and amortization expenses from gross profit, operating expenses and operating loss.  The non-GAAP financial measures used by management and disclosed by us are not a substitute for, or superior to, financial measures and consolidated financial results calculated in accordance with GAAP, and you should carefully evaluate our reconciliations to non-GAAP.  We may calculate our non-GAAP financial measures differently
'/>"/>

SOURCE Uroplasty, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Uroplasty To Participate In The Oppenheimer 23rd Annual Healthcare Conference
2. Uroplasty To Participate In Two Upcoming Investor Conferences
3. Uroplasty Reports Fiscal Second Quarter 2013 Financial Results
4. Uroplasty To Participate In Two Upcoming Conferences
5. Uroplasty Reports Fiscal First Quarter 2013 Financial Results
6. Uroplasty to Issue First Quarter of Fiscal 2013 Financial Results on July 26, 2012
7. Uroplasty To Present At The JMP Securities Healthcare Conference
8. Uroplasty Reports Fiscal Fourth Quarter And Full Year 2012 Financial Results
9. Uroplasty Announces Product Development and New Clinical Trial Initiatives
10. Uroplasty to Present at the 11th Annual JMP Securities Research Conference
11. Cepheid Reports Fourth Quarter And Full Year 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Tegra Medical is very pleased to announce the appointment of ... Executive Officer.  Mark was promoted from his current role of ... four facilities in Massachusetts , ... Medical in 2012 with 20+ years of broad-based operations, sales, ...
(Date:1/15/2014)...  Echo Therapeutics, Inc. (Nasdaq: ECTE ) ("Echo"), ... as a non-invasive, wireless continuous glucose monitoring system, today ... and Interim CEO of Echo Therapeutics, will present at ... Mr. Doman will make a corporate ...
(Date:1/15/2014)... , Jan. 15, 2014  According to Millennium Research ... market intelligence, the United States ... device markets will expand moderately through 2022, with ... In particular, increasing interest in drug-eluting beads (DEBs) ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty ... and Chief Executive Officer, will provide an overview and update ... Lynch 2012 Healthcare Conference on Wednesday, May 16, 2012 at ... in Las Vegas, Nevada. The presentation will be webcast live ...
...  Express Scripts, Inc. (Nasdaq: ESRX ) announced that ... 2012 Healthcare Conference on May 16, 2012 at 1:00 p.m. ... in Las Vegas, Nevada. This presentation will also ... the investor relations section of Express Scripts, web site at ...
Cached Medicine Technology:Watson to Present at the Bank of America Merrill Lynch 2012 Health Care Conference 2
(Date:4/17/2014)... that India,s shocking rates of suicide are highest in ... to tiny smallholdings less than one hectare ... and coffee, that are highly susceptible to global price ... case studies that point to a crisis in key ... the nation,s economy during the 90s. Researchers say that ...
(Date:4/17/2014)... after they suffer a cardiac arrest outside of a ... according to new research conducted at St. Michael,s Hospital. ... cardiac arrest get adrenaline, which has been the drug ... Steve Lin, an emergency physician and trauma team leader ... long-term survival rates of patients who suffer a cardiac ...
(Date:4/17/2014)... treatment that lost its status as the leading weapon ... lease of life, with new research indicating it simply ... revive the use of the cheap anti-malarial drug chloroquine ... the lives of more than half a million people ... causes malaria has developed resistance to chloroquine, but research ...
(Date:4/16/2014)... marvel of the embryo. It begins as a glob of ... to become the cells of our lungs, muscles, nerves and ... in a feat of reverse tissue engineering, Stanford University researchers ... embryonic cells to proliferate and transform into all of the ...
(Date:4/16/2014)... HAMPTON, NJ (April 16, 2014): Celldex Therapeutics, Inc. ... Phase 1 study of CDX-1401 in solid tumors, including ... Translational Medicine (Vol 6 Issue 232). The data ... of clinical benefit in patients with very advanced cancers ...
Breaking Medicine News(10 mins):Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 3Health News:Adrenaline does little to increase patient's survival after cardiac arrest 2Health News:Scientists find new way to fight malaria drug resistance 2Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 2Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 3Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 2Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 3Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 4
... developed a blood test for early detection of ovarian cancer//. ... as it is very difficult to diagnose during its early ... of the ovaries, like the surface epithelial cells, germ cells, ... women is ranked 4th in terms of causing deaths due ...
... said that it is better// to go for surgery while ... see if the disease progresses. ,Surgery for treating prostate ... researchers had conducted he study to see if prostatectomy done ... than watching and waiting the cancer in the prostate gland ...
... reduce the risk of kidney failure in men.// ,The ... of alcohol weekly (about a glass a day) and compared ... men who drank less than a glass a day of ... function of these men through a period of 14 years. ...
... study published in the May issue of the journal Neurology ... may be competent to take decisions about their treatments, but ... not remain competent to do so. ,The study also ... and its growth in the mare more likely to take ...
... cholesterol in the blood can increase the risk of having ... recent issue of British Journal of Cancer says that the ... testicular cancer by almost as much as 4.5 % than ... Swedish researchers from Karolinska University Hospital had looked into the ...
... pregnancy not only decides the health// of the fetus, it ... ,In a study to understand fetal development and mother’s ... on the genetic code of the fetus that may affect ... provided evidence that adverse effects of intrauterine environments can be ...
Cached Medicine News:
The world's first and only laser surgical device combining irrigation and aspiration comfortable and precisely. This innovative combination is used for advanced small incision intraocular surgery....
The unprecedented power, flexibility and versatility of the Series 20000 Legacy have made it the world's leading phacoemulsifier....
Aaron Burr II with disposable 1mm burr for corneal rust ring removal and a diamond burr tip for polishing the pterygium bed after surgical removal and for lid margin lesions....
Foreign body removal system. Designed to aid in the removal of foreign bodies and corneal rust rings. Ophtho-burr handpiece only. Battery powered handpiece....
Medicine Products: